Hosted on MSN3h
FDA approves 1st new class of opioid-free painkillers in over 20 years
The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.
Wiltshire Times20h
Free training aims to keep Wiltshire pub-goers safe
Welfare and Vulnerability Engagement (WAVE) training educates bar and pub staff on identifying potentially vulnerable customers, with the goal of curbing violent crime, sexual offences, and drug or ...
Inspection of meat shops, food vendors initiated to check contamination
Following the GBS disease outbreak with cases reported in clusters from Sinhgad Road, Nande Village, Kirkitwadi, Dhayari and DSK Vishwa amongst other areas the State government and PMC issued directio ...
The Actual Benefits of Red Light Therapy, According to Doctors
Other research has shown red light therapy could minimize the appearance of wrinkles, hyperpigmentation, and broken blood ...
Scientific American4h
What Is Journavx, the New Opioid-Free Painkiller from Vertex?
The nonaddictive painkiller suzetrigine (Journavx) is as effective for acute pain as a common opioid treatment ...
About half of Americans approve of using weight-loss drugs to treat obesity, AP-NORC poll finds
A new poll from The Associated Press-NORC Center for Public Affairs Research shows about half of U.S. adults believe it is a good thing for adults to use weight-loss drugs like Ozempic, Wegovy and ...
FDA approves new painkiller that shows promise and challenges of opioid alternatives
The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often ...